Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.255
|
0.286
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
0.257
|
0.291
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
0.261
|
0.305
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
0.257
|
0.302
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
0.257
|
0.303
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
0.256
|
0.298
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
0.261
|
0.302
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
0.26
|
0.303
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
0.271
|
0.303
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
0.271
|
0.303
|
0.281
|
0.281
|
0.281
|
0.281
|
|
|
|
|
BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids.